Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Ministry of Health, Malaysia.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
GeneNews Sdn Bhd
Information provided by:
Ministry of Health, Malaysia
ClinicalTrials.gov Identifier:
NCT01310062
First received: March 4, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted

March 4, 2011
March 4, 2011
August 2010
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Not Provided
Observational
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:

Red blood cell and white blood cell

Non-Probability Sample

Selected hospitals for study

  • Hepatitis B,Chronic
  • Carcinoma,Hepatocellular
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1600
August 2012
Not Provided

Inclusion Criteria:

  • Patients of at least 21 years old on day of giving consent for study
  • Patients must be able and wiling to give an informed consent
  • Patient with chronic HBV infection
  • Patient with active hepatocellular carcinoma and chronic hepatitis B
  • Healthy subjects

Exclusion Criteria:

  • Patients who have co-infection with HIV or chronic hepatitis C
  • Subjects with other types of cancer
Both
21 Years and older
Yes
Contact: Clinical Research Centre +603-40439300 ext 113 shanthini@crc.gov.my
Malaysia
 
NCT01310062
09-317-3991
No
Professor Dato' Dr. Liew Choong Chin, GeneNews Sdn Bhd
Ministry of Health, Malaysia
GeneNews Sdn Bhd
Not Provided
Ministry of Health, Malaysia
March 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP